Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

NCT01401322 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01401322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01401322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2011
Completion date
May 31, 2012
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, relapsed adult acute lymphocytic leukemia